Drawing for MAVANCLAD

USPTO serial 79207880

MAVANCLAD

Reviewed by CopyMark Law Group

Reg. 5314424Status 709
Filing date
Status date
Registration date
Oct 24, 2017
Examiner
TENG, SIMON
Law office
PETITIONS OFFICE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MAVANCLAD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products, namely, pharmaceutical preparations for the treatment of inflammatory and immunological diseases and disordersSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 19, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Mar 29, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Mar 29, 2025INPCINVALIDATION PROCESSED—
Jan 11, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 10, 2024C71TCANCELLED SECTION 71—
Oct 24, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 16, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 29, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 29, 2018FIMPFINAL DISPOSITION PROCESSED—
Jan 24, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 24, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 27, 2017CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Sep 26, 2017APETASSIGNED TO PETITION STAFF—
Sep 5, 2017EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Aug 8, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 8, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 19, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 1, 2017RFNTREFUSAL PROCESSED BY IB—
Jun 29, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 29, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 29, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 29, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 29, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 9, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 9, 2017RFRRREFUSAL PROCESSED BY MPU—
May 30, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
May 27, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 26, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 25, 2017DOCKASSIGNED TO EXAMINER—
May 25, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 18, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance